Trial
NCT04166383
VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Metastatic Colorectal Cancer
Intervention
Vascular Biogenics (VB)-111
Why stopped
Interim analysis indicated limited efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-10